Trial reportThe American journal of orthopsychiatry2019
Feasibility, preliminary efficacy, and safety of a randomized clinical trial for Asian Women's Action for Resilience and Empowerment (AWARE) intervention.
Trial report in The American journal of orthopsychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Cultural Adaptations to the Assessment and Treatment of Trauma Experiences Among Racial and Ethnic Minority Groups: A Mixed-Methods Systematic Review and Meta-Analysis.Trauma, violence & abuse · 2026Pooled it
- The mediating role of neuroception of psychological safety in the relationship between traumatic experiences and aggressive behaviors among inpatients with mental disorders.Frontiers in public health · 2026Article
- The Association Between Racial Microaggressions and Stereotypes and Self-Rated Mental Health in Asian Women.International journal of environmental research and public health · 2025Article
- Trends and Disparities in Mental Health Use Among Asian American Sub-groups, 2013-2019.Journal of racial and ethnic health disparities · 2025Article
- Correlates of Stigma Toward Mental Health Service Use Among Filipino Americans and Korean Americans.Journal of immigrant and minority health · 2023Article
- Substance use disorders and treatment in Asian American and Pacific Islander women: A scoping review.The American journal on addictions · 2023Article
- Youth Suicide During the First Year of the COVID-19 Pandemic.Pediatrics · 2023Article
- HIV Knowledge, Risk Behaviors, and Testing Among Chinese-, Korean-, and Vietnamese-American Women.Journal of health science & education · 2023Article
- Preliminary efficacy of AWARE in college health service centers: A group psychotherapy intervention for Asian American women.Journal of American college health : J of ACH · 2022Article
- Congruence and discrepancy in Asian American women's perception and stress appraisal of gendered racial microaggressions: Relationships with depressive symptoms and internalized racism.Frontiers in public health · 2022Article
- Perceived COVID-19-related anti-Asian discrimination predicts post traumatic stress disorder symptoms among Asian and Asian American young adults.Psychiatry research · 2021Article
- Guest editors' introduction to the special section: Cultural adaptation of mental health interventions for Americans of East Asian descent.The American journal of orthopsychiatry · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
To our knowledge, Asian Women's Action for Resilience and Empowerment (AWARE) is the first gender- and culture-specific and trauma-informed group psychotherapy intervention designed for Asian-American young women with histories of interpersonal violence and trauma and/or Post-Traumatic Stress Disorder (PTSD) diagnosis. We employed a 2-arm randomized controlled trial. Sixty-three women who met clinical criteria for trauma were randomized to the intervention (n = 32) or waitlist control (n = 31) group. We documented retention rates, preliminary efficacy for sexual risk behaviors and depressive symptoms (overall and stratified by PTSD at baseline), and safety in terms of suicidality at baseline, postintervention, and 3-month follow-up. AWARE demonstrated high retention rates, in that 87.50% of those enrolled in the program completed at least 6 out of the 8 sessions. Although there were no differences overall for sexual risk behaviors or depressive symptoms, among women with PTSD, significant reductions in depressive symptoms were observed in treatment compared to control, with an effect size of .84. Suicidal ideation and intent were reduced in both the treatment and control groups, with no attempts during the trial. AWARE is uniquely tailored to serve a pressing clinical need. These results support its feasibility and safety. A large-scale trial targeted at women with PTSD is recommended to further explore the efficacy of AWARE. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.